411 related articles for article (PubMed ID: 9610911)
1. Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination.
Sensi M; Farina C; Maccalli C; Anichini A; Berd D; Parmiani G
J Immunother; 1998 May; 21(3):198-204. PubMed ID: 9610911
[TBL] [Abstract][Full Text] [Related]
2. Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine.
Sensi M; Farina C; Maccalli C; Lupetti R; Nicolini G; Anichini A; Parmiani G; Berd D
J Clin Invest; 1997 Feb; 99(4):710-7. PubMed ID: 9045874
[TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of TCRBV diversity in T lymphocytes present in blood, metastatic lesions, and DTH sites of two melanoma patients vaccinated with an IL-7 gene-modified autologous tumor cell vaccine.
Carsana M; Tragni G; Nicolini G; Bersani I; Parmiani G; Anichini A; Sun YS; Möller P; Schadendorf D; Sensi ML
Cancer Gene Ther; 2002 Mar; 9(3):243-53. PubMed ID: 11896440
[TBL] [Abstract][Full Text] [Related]
4. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines.
Shilyansky J; Nishimura MI; Yannelli JR; Kawakami Y; Jacknin LS; Charmley P; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2829-33. PubMed ID: 7511820
[TBL] [Abstract][Full Text] [Related]
5. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M; Salvi S; Castelli C; Maccalli C; Mazzocchi A; Mortarini R; Nicolini G; Herlyn M; Parmiani G; Anichini A
J Exp Med; 1993 Oct; 178(4):1231-46. PubMed ID: 8376931
[TBL] [Abstract][Full Text] [Related]
6. Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases.
Corbière V; Chapiro J; Stroobant V; Ma W; Lurquin C; Lethé B; van Baren N; Van den Eynde BJ; Boon T; Coulie PG
Cancer Res; 2011 Feb; 71(4):1253-62. PubMed ID: 21216894
[TBL] [Abstract][Full Text] [Related]
7. Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.
Serana F; Sottini A; Caimi L; Palermo B; Natali PG; Nisticò P; Imberti L
J Transl Med; 2009 Mar; 7():21. PubMed ID: 19317896
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T-lymphocyte clones from different patients display limited T-cell-receptor variable-region gene usage in HLA-A2-restricted recognition of the melanoma antigen Melan-A/MART-1.
Sensi M; Traversari C; Radrizzani M; Salvi S; Maccalli C; Mortarini R; Rivoltini L; Farina C; Nicolini G; Wölfel T
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5674-8. PubMed ID: 7777568
[TBL] [Abstract][Full Text] [Related]
9. TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine.
Manne J; Mastrangelo MJ; Sato T; Berd D
J Immunol; 2002 Sep; 169(6):3407-12. PubMed ID: 12218163
[TBL] [Abstract][Full Text] [Related]
10. Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens.
Linette GP; Becker-Hapak M; Skidmore ZL; Baroja ML; Xu C; Hundal J; Spencer DH; Fu W; Cummins C; Robnett M; Kaabinejadian S; Hildebrand WH; Magrini V; Demeter R; Krupnick AS; Griffith OL; Griffith M; Mardis ER; Carreno BM
Proc Natl Acad Sci U S A; 2019 Nov; 116(47):23662-23670. PubMed ID: 31685621
[TBL] [Abstract][Full Text] [Related]
11. High frequency of T cell clonal expansions in primary human melanoma. Involvement of a dominant clonotype in autologous tumor recognition.
Pisarra P; Mortarini R; Salvi S; Anichini A; Parmiani G; Sensi M
Cancer Immunol Immunother; 1999 Apr; 48(1):39-46. PubMed ID: 10235487
[TBL] [Abstract][Full Text] [Related]
12. TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients.
Maccalli C; Farina C; Sensi M; Parmiani G; Anichini A
J Immunol; 1997 Jun; 158(12):5902-13. PubMed ID: 9190943
[TBL] [Abstract][Full Text] [Related]
13. Dominant TCRB-V-J chain usage and clonal expansion of sarcoma-reactive CD4+ HLA-DR-restricted T cells suggest a limited set of immunodominant sarcoma antigens.
Heike M; Duchmann R; May E; Schulze-Bergkamen H; Schmitt U; Meyer zum Büschenfelde KH
Int J Cancer; 1997 Jul; 72(3):403-7. PubMed ID: 9247281
[TBL] [Abstract][Full Text] [Related]
14. Polyclonal CTL responses observed in melanoma patients vaccinated with dendritic cells pulsed with a MAGE-3.A1 peptide.
Godelaine D; Carrasco J; Lucas S; Karanikas V; Schuler-Thurner B; Coulie PG; Schuler G; Boon T; Van Pel A
J Immunol; 2003 Nov; 171(9):4893-7. PubMed ID: 14568970
[TBL] [Abstract][Full Text] [Related]
15. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
Cole DJ; Wilson MC; Rivoltini L; Custer M; Nishimura MI
Cancer Res; 1997 Dec; 57(23):5320-7. PubMed ID: 9393756
[TBL] [Abstract][Full Text] [Related]
16. T cell-receptor V gene use by CD4+ melanoma-reactive clonal and oligoclonal T-cell lines.
Nishimura MI; Custer MC; Schwarz SL; Parker LL; Mixon A; Clay TM; Yannelli JR; Rosenberg SA
J Immunother; 1998 Sep; 21(5):352-62. PubMed ID: 9789197
[TBL] [Abstract][Full Text] [Related]
17. T-cell receptor repertoire in tumor-infiltrating lymphocytes. Analysis of melanoma-specific long-term lines.
Nishimura MI; Kawakami Y; Charmley P; O'Neil B; Shilyansky J; Yannelli JR; Rosenberg SA; Hood L
J Immunother Emphasis Tumor Immunol; 1994 Aug; 16(2):85-94. PubMed ID: 7804531
[TBL] [Abstract][Full Text] [Related]
18. Multiple specificities in the repertoire of a melanoma patient's cytolytic T lymphocytes directed against tumor antigen MAGE-1.A1.
Romero P; Pannetier C; Herman J; Jongeneel CV; Cerottini JC; Coulie PG
J Exp Med; 1995 Oct; 182(4):1019-28. PubMed ID: 7561675
[TBL] [Abstract][Full Text] [Related]
19. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
[TBL] [Abstract][Full Text] [Related]
20. Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination.
Lee KH; Panelli MC; Kim CJ; Riker AI; Bettinotti MP; Roden MM; Fetsch P; Abati A; Rosenberg SA; Marincola FM
J Immunol; 1998 Oct; 161(8):4183-94. PubMed ID: 9780192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
